Skip to main content
. 2020 Jun 10;10:9378. doi: 10.1038/s41598-020-66296-z

Figure 3.

Figure 3

Protein network by MetaCore built with the differential proteins found (blue spheres) adding FGFR1, VEGFR-1, PDGF receptor, known to be targets of the Nintedanib treatment. PDGF-R-beta, FGFR1, VEGFR-1, HP, PDGF receptor result central hubs. Green edges indicate «induction», red edges are correlated with inhibition, while grey edges indicate an unspecified effect. Bold light blue line represent well-known canonical pathways.